Skip to content
YCW20· Other

Isabl

Cancer tests based on whole genome and transcriptome data.

ActiveChecked 24h ago
Batch
W20
Status, per YC
Active
Team size
5
HQ
New York City, NY
In W20228 companies, 29% AI
isabl.ioYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Isabl

Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations. Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.

New York City, NY, USA; New York, NY, USA; Remote

Isabl: questions

Which YC batch was Isabl in?

Isabl was in Y Combinator's Winter 2020 batch (W20).

Is Isabl still active?

Y Combinator lists Isabl as active.

Where is Isabl based?

Isabl lists New York City, NY, USA; New York, NY, USA; Remote as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.